F Krummenauer1, M Braun, H B Dick. 1. Institut für Medizinische Biometrie und Epidemiologie und Informatik, Universität, Mainz. krummi@imbei.uni-mainz.de
Abstract
BACKGROUND: The efficacy of PDT to prevent the progression of AMD has been established. This study now assesses the patients' quality of life and self-reported satisfaction after PDT. MATERIAL AND METHODS: All patients who underwent PDT during 2000 and 2001 at the University Eye Hospital of Mainz were interviewed using an AMD-specific modification of a standardized 82-item questionnaire on quality of life and satisfaction in ophthalmological patients. Different aspects of those parameters were derived as scores, which were then related to clinical outcome parameters. RESULTS: During the period of PDT treatment, the median decrease in visual acuity was three stages in the patients examined. Patients who reported a subjective increase in visual function during this period showed for example a median "private flexibility" score of 1.86, and patients with the subjective impression of a decrease in visual function a median score of 2.71. CONCLUSION: The established clinical efficacy of PDT treatment to prevent AMD progression coincides with an encouraging patient satisfaction after the treatment.
BACKGROUND: The efficacy of PDT to prevent the progression of AMD has been established. This study now assesses the patients' quality of life and self-reported satisfaction after PDT. MATERIAL AND METHODS: All patients who underwent PDT during 2000 and 2001 at the University Eye Hospital of Mainz were interviewed using an AMD-specific modification of a standardized 82-item questionnaire on quality of life and satisfaction in ophthalmological patients. Different aspects of those parameters were derived as scores, which were then related to clinical outcome parameters. RESULTS: During the period of PDT treatment, the median decrease in visual acuity was three stages in the patients examined. Patients who reported a subjective increase in visual function during this period showed for example a median "private flexibility" score of 1.86, and patients with the subjective impression of a decrease in visual function a median score of 2.71. CONCLUSION: The established clinical efficacy of PDT treatment to prevent AMD progression coincides with an encouraging patient satisfaction after the treatment.
Authors: Barbara L Brody; Anne-Catherine Roch-Levecq; Anthony C Gamst; Kellie Maclean; Robert M Kaplan; Stuart I Brown Journal: Arch Ophthalmol Date: 2002-11
Authors: Paul J Mackenzie; Tom S Chang; Ingrid U Scott; Mark Linder; Dawn Hay; William J Feuer; Keith Chambers Journal: Ophthalmology Date: 2002-04 Impact factor: 12.079
Authors: A C Marti; F K P Sutter; D Barthelmes; J C Fleischhauer; M M Kurz-Levin; M M Bosch; H Helbig Journal: Ophthalmologe Date: 2007-02 Impact factor: 1.059